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Abstract
Background and Purpose—Ultrasonographic plaque echolucency has been studied as a
stroke risk marker in carotid atherosclerotic disease. We performed a systematic review and metaanalysis to summarize the association between ultrasound determined carotid plaque echolucency
and future ipsilateral stroke risk.
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Methods—We searched the medical literature for studies evaluating the association between
carotid plaque echolucency and future stroke in asymptomatic patients. We included prospective
observational studies with stroke outcome ascertainment after baseline carotid plaque echolucency
assessment. We performed a meta-analysis and assessed study heterogeneity and publication bias.
We also performed subgroup analyses limited to patients with stenosis ≥50%, studies in which
plaque echolucency was determined via subjective visual interpretation, studies with a relatively
lower risk of bias, and studies published after the year 2000.
Results—We analyzed data from 7 studies on 7557 subjects with a mean follow up of 37.2
months. We found a significant positive relationship between predominantly echolucent
(compared to predominantly echogenic) plaques and the risk of future ipsilateral stroke across all
stenosis severities (0-99%) (relative risk [RR], 2.31, 95% CI, 1.58-3.39, P<.001) and in subjects
with ≥50% stenosis (RR, 2.61 95% CI, 1.47-4.63, P=.001). A statistically significant increased RR
for future stroke was preserved in all additional subgroup analyses. No statistically significant
heterogeneity or publication bias was present in any of the meta-analyses.

Corresponding Author: ajg9004@med.cornell.edu; 525 East 68th Street, Starr 8A, Box 141, New York, NY 10065; 212-746-2573
(tel); 212-746-8597 (fax).
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Conclusions—The presence of ultrasound-determined carotid plaque echolucency provides
predictive information in asymptomatic carotid artery stenosis beyond luminal stenosis. However,
the magnitude of the increased risk is not sufficient on its own to identify patients likely to benefit
from surgical revascularization.
Keywords
carotid stenosis; ultrasound; plaque; stroke; risk factor

Introduction
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Two randomized controlled trials found that carotid endarterectomy can reduce the annual
risk of stroke in asymptomatic patients with 50-99% carotid artery stenosis to 0.5-1.0%.1,2
However, the clinical relevance of these results has been questioned since progressive
improvements in medical therapy have significantly reduced the annual stroke rate in
asymptomatic carotid stenosis. For example, a meta-analysis3 demonstrated that when
taking into account studies completing recruitment of asymptomatic carotid stenosis subjects
between 2000 and 2010, the annual ipsilateral stroke rate is approximately 1%, and
potentially even lower when only the most recent observational data included in this metaanalysis are considered. For this reason, and due to the marginal surgical stroke prevention
benefit seen in the randomized trials, investigations have focused on improving risk
stratification strategies beyond luminal stenosis measurements.
Ultrasound is an attractive potential tool for obtaining stroke risk information in carotid
disease since it is widely available and has almost no contraindications. The use of carotid
plaque echolucency as a potential marker for stroke risk is supported by histopathologic
studies showing that plaque echolucency corresponds to lipid-rich necrotic core or
intraplaque hemorrhage, more commonly found in symptom-associated carotid stenosis than
in asymptomatic stenosis.4,5 However, there are conflicting data in the literature regarding
the predictive value of carotid plaque echolucency in asymptomatic patients6,7 and the small
study samples studied result in wide confidence intervals for risk estimates. For these
reasons, we performed a systematic review and meta-analysis evaluating whether ultrasound
characterization of carotid plaque echogenicity is a predictor of ipsilateral stroke in
asymptomatic carotid atherosclerotic disease.
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Methods
This study followed guidelines presented in the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses statement.8
Study Eligibility Criteria
Studies with ultrasound characterization of carotid artery plaque echolucency in subjects
subsequently followed for development of future ipsilateral stroke were eligible. Specific
inclusion criteria were: (1) English language manuscripts; (2) studies with at least 30
subjects; (3) studies of asymptomatic patients without histories of prior ipsilateral stroke or
TIA at the time of imaging; (4) ultrasound determination of the presence or absence of
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carotid vessel plaque echolucency in subjects with carotid plaque (both stenosis-causing and
non-stenosing plaques); (5) mean follow-up >12 months after plaque imaging; (6) clinical
ascertainment of first time ipsilateral stroke during follow-up; and (7) non-surgical
management of patients with follow-up information on greater than 85% of the initially
asymptomatic cohort enrolled in the study. If a mixed cohort of previously symptomatic and
asymptomatic patients or medically and surgically treated patients were presented, such a
study was included if the ultrasound test and stroke outcome data for only the patients who
were asymptomatic at baseline could be extracted from the manuscript. In cases where the
ultrasound test result or outcome data were not clear in the manuscript, we attempted to
contact the corresponding author for additional details. Furthermore, if ultrasound test data
from a cohort was published more than once, only the originally published paper was used
for the testing data and outcome results to avoid pooling duplicate results. Finally, if more
than one method of echolucency determination was presented in a manuscript, the method
with the greatest predictive ability was included in the meta-analysis.
Information Search and Data Collection
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We performed systematic searches of multiple medical literature databases between January
and March of 2014 to find all eligible articles without regard to when they were published.
Major search terms for all databases included “carotid stenosis,” “plaque,” “atherosclerosis,”
“ultrasound,” “sonography,” “doppler,” “stroke,” and “transient ischemic attack.” The
search methodology details and data extraction process are provided in the Methods in the
Online Supplement (please see http://stroke.ahajournals.org).
Assessment of Risk of Bias in Studies
We used the following bias assessment criteria which we adapted from published metaanalyses9,10 of imaging markers of stroke risk in carotid disease: (1) risk of outcome
ascertainment bias, for which we assessed whether investigators were blinded to ultrasound
testing results when stroke outcomes were assessed; (2) risk of confounding bias, for which
we assessed whether potentially confounding stroke risk factors were collected and
analyzed; (3) completeness of follow-up data, for which we assessed whether losses to
follow-up were systematically recorded and reported.
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Statistical Analyses
We performed a meta-analysis of studies meeting two criteria: (1) a relative risk (RR) was
calculable from the raw data either as published or obtained via direct correspondence from
the study author(s); (2) echolucency test results were presented in a dichotomized fashion
(e.g., predominantly echolucent versus echogenic) or in a categorical fashion that could be
dichotomized in the data extraction process. We used the Q statistic to determine study
heterogeneity and the Begg test for publication bias. We performed all analyses using a
random-effects model in which we made the conservative assumption that included studies
did not have exactly the same effect size (relative risk). Given the potential for heterogeneity
between studies in terms of sample size, patient characteristics, and testing methods, we did
not employ a fixed-effects model since in this approach an identical effect size is assumed
across all studies.
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We performed 2 primary analyses from the studies in which ultrasound test data could be
extracted, 1 including all patients (with all stenosis severities from 0 to 99%) and 1 limited
to patients with ≥50% stenosis. The analysis limited to patients with ≥50% stenosis was
performed by extracting this data from details provided in the manuscript or via direct
correspondence with the author. We also performed 3 additional prespecified subgroup
analyses limited to the following study characteristics: (1) studies in which authors were
blinded to imaging test data during outcome ascertainment and analyzed potentially
confounding vascular risk factors; (2) studies in which plaque echolucency determination
was made by subjective visual interpretation without quantitative imaging postprocessing;
(3) studies published since 2000. We also performed 3 post-hoc sensitivity analyses: (1)
excluding Polak et al.11 to evaluate the possibility that its cohort of 4,886 subjects could be
significantly driving the effect size of the overall meta-analysis; (2) excluding Silvestrini et
al.12 given its use of an imaging-based (time-independent) definition of stroke, unlike the
time-dependent, clinical definitions used in all other studies; and (3) excluding Topakian et
al.7 given that a subset of its subjects developed TIAs prior to stroke outcome ascertainment.

Results
NIH-PA Author Manuscript

Study Selection
We screened a total of 5,409 abstracts from which 8 manuscripts6,7,11-16 were ultimately
deemed to meet all inclusion criteria for the systematic review. Study selection steps are
summarized in Online Supplement Figure I (please see http://stroke.ahajournals.org)
Qualitative Assessment and Study Characteristics
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Of the 8 articles meeting inclusion criteria for qualitative review and pooling (Table 1), all
were prospective, longitudinal non-randomized observational studies with 2 conducted as
international multicenter studies,7,15 2 in the United States,11,16 and 1 each in Australia,13
Denmark,6 Italy,12 and Norway.14 All evaluated patients with similar mean ages (range 64.0
to 72.6 years) and all except 1 study11 had a preponderance of male subjects (range 43% to
84.2% male). We found considerable differences in the degree of extracranial carotid artery
stenosis studied, with 5 studies11,13-16 including a combination of subjects with low (<50%),
moderate (50-69%), and high-grade (≥70%) stenosis. Of these 5 studies, 2 included a
number of subjects who did not have stenosed carotid arteries13,14 and 1 study11 included a
number of subjects without carotid plaque (stenosing or non-stenosing). The remaining 3
studies6,7,12 were limited to moderate and high-grade carotid stenosis subjects. Subjects in
all studies were followed for at least 21.8 months (range 21.8-52.8 months) for
ascertainment of clinically-defined first-time stroke. The definition of asymptomatic carotid
stenosis was not always explicitly given11, 14, 16 or sometimes included patients with remote
ipsilateral symptoms (>12-24 months) as asymptomatic patients.7,13
Ultrasound test results and outcomes in each test group are summarized in Tables 2 and 3
with additional details about the cohort with >50% stenosis summarized in Online
Supplement Table I (please see http://stroke.ahajournals.org). Seven studies6,7,11,13-16
defined stroke clinically as ipsilateral hemispheric neurologic deficit but only 3 of these 7
studies6,14,15 stipulated specifically that the deficit must be present for >24 hours to be
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defined as a stroke. One study, Silvestrini et al.12, utilized time-independent clinical features
with brain imaging evidence of cerebral ischemia to define stroke. This meant that some
transient events (most likely called TIAs in all the other studies we included) were classified
as stroke in the study by Silvestrini et al. Of the 8 studies meeting inclusion criteria for the
systematic review, 7 were amenable to the calculation of a RR of ipsilateral stroke in the
presence of plaque echolucency. In the 1 other study13 the authors presented only a
composite outcome measure of TIA plus stroke which prevented this study from being
included in the pooled ipsilateral stroke RR calculation. In 6 of studies included in the
systematic review, RR information for asymptomatic patients was either presented or could
be calculated from the raw data provided in the manuscript. In the remaining 2 studies12,14
mixed cohorts of symptomatic and asymptomatic patients at baseline were presented for
which we were able to obtain test and outcome data for the asymptomatic patients only after
correspondence with the study authors.
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Definitions of ultrasound testing methods, imaging equipment, abnormal test results, and
outcome measures are provided in Table 4. For all studies we were able to dichotomize test
results into positive or negative for echolucency, using definitions provided by the study
authors. All studies used standard clinical ultrasound equipment. In addition, all studies
except 26,15 employed subjective observer interpretation of plaque echolucency as the
definition of a positive test result.
Assessments of Study Methods
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In 5 of the 8 studies6,7,11,12,14 the authors described a process of blinding of ultrasound
results in the determination of clinical outcomes while in the remaining 3 studies blinding
was not described. In 7 of the included studies, the authors recorded potentially confounding
risk factors with only 1 study16 not including these data. Finally, in 2 studies there was a
description of the exact numbers of subjects who were lost to follow-up (12 subjects in 1
study15 and 2 in another14) while in 1 study13 there was mention that some loss to follow-up
had occurred without presenting the actual numbers. There was no mention of loss to
follow-up in the remaining studies. Furthermore, in only 4 studies7,12,14,15 was the
proportion of subjects undergoing surgical revascularization while asymptomatic provided.
Finally, in 1 study7 patients who were asymptomatic at baseline were followed up until their
first ipsilateral stroke, whether or not they had an ipsilateral TIA first. Therefore, in this
study a mixture of asymptomatic and symptomatic patients were included in stroke event
rates and correlations with plaque characteristics.
Meta-Analysis Results for all Subjects including those with and without Stenosis
In this primary analysis we studied 7,557 subjects with a mean follow up of approximately
37.2 months yielding a total of 23,410.2 person-years of follow-up. No significant
heterogeneity (Q=9.438, P=0.150) or publication bias (Kendall’s score=7, P=0.293) was
present in this primary analysis. We found a significant positive relationship between plaque
echolucency and the risk of future ipsilateral stroke with a random effects RR of 2.31 (95%
confidence interval [CI], 1.58-3.39, P<.001) (Figure 1). Of the total study sample, 1,741
subjects (23.0%) had a positive ultrasound test for echolucency while 5,816 (77.0%) had a
negative test for echolucency. In the echolucent positive test group, 100 ipsilateral strokes
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occurred compared to 141 ipsilateral strokes in the echolucent negative test group. The
cumulative incidence of ipsilateral stroke in the echolucent plaque cohort was 5.7%
compared to 2.4% in the non-echolucent plaque cohort.
Meta-Analysis Results for Moderate and High-Grade Carotid Stenosis
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In our analysis limited to subjects with ≥50% extracranial carotid stenosis,6,7,12,15,16 we
accumulated 2,095 subjects with a mean follow up of approximately 29.7 months yielding a
total of 5,185.1 person-years of follow-up (Figure 2). No significant heterogeneity (Q=8.216
P=0.084) or publication bias (Kendall’s score=0, P=1.000) was present in this subgroup
analysis. In patients with ≥50% carotid stenosis, we found a significant positive relationship
between plaque echolucency and the risk of future ipsilateral stroke with a random effects
RR of 2.61 (95% CI, 1.47-4.63, P=.001) (Figure 2). Of the moderate to high-grade stenosis
patient sample, 649 subjects (31.0%) had a positive ultrasound test for echolucency while
1,446 (69.0%) had negative test for echolucency. In the echolucent positive test group, 67
ipsilateral strokes occurred compared to 59 ipsilateral strokes in the echolucent negative test
group. The cumulative incidence of ipsilateral stroke in the moderate and high-grade
stenosis echolucent plaque cohort was 10.3% compared to 4.1% in the non-echolucent
plaque cohort.
Subgroup Meta-analysis Results
No significant heterogeneity or publication bias was found in any of the subgroup or
sensitivity analyses (Table 4). A statistically significant random-effects RR was preserved in
subgroup analyses involving: (1) only those studies where test result blinding and analysis of
confounding stroke risk factors occurred (RR 2.03, 95% CI 1.26-3.27), (2) only those
studies in which echolucency was determined by subjective visual interpretation (RR 2.73,
95% CI 1.76-4.22), (3) only those studies which were published after 2000 (RR 2.14, 95%
CI 1.28-3.59). Likewise, a statistically significant random-effects RR was also preserved in
the 3 post-hoc sensitivity analyses performed and the magnitude of the RR was not sizably
different.

Discussion
NIH-PA Author Manuscript

The degree of carotid stenosis criteria alone within the 50-99% range provides only a
relatively weak means for clinically stratifying the risk for ipsilateral stroke in asymptomatic
patients.18,19 In this systematic review and meta-analysis of over 7,500 patients, we studied
plaque echogenicity as an additional marker of stroke risk. We found that patients with
predominantly echolucent plaques had an approximately 2.3 fold higher risk of future
ipsilateral stroke than those with predominantly echogenic plaques. In patients with 50-99%
carotid stenosis, we also found an approximately 2.6-fold higher risk of ipsilateral stroke if
the plaques were predominantly echolucent compared to plaques which were not
predominantly echolucent.
Furthermore, in 3 additional prespecified subgroup analyses we showed that the increased
risk of ipsilateral stroke noted in patients with echolucent plaques was robust to differences
in patient samples, study methodology, and study era. Specifically, we showed that the
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subjective visual interpretation of echolucency also identified higher risk subgroups in our
pooled analysis without the use of quantitative gray-scale median analysis of plaque 6 or
post processing image normalization.15 However, the relative performance of subjective,
visually-determined echolucency versus quantitative, computer-based methods requires
further investigation since only 2 studies6,15 in our meta-analysis used computer-aided
methods thereby preventing a meaningful comparison of the techniques. In addition, after
excluding studies with a relatively higher risk of outcome ascertainment and confounding
bias, there was a preserved statistically significant RR. Moreover, we found that the risk of
stroke was increased with echolucent plaque even when the analysis was limited to
publications after the year 2000, an era in which improvements to medical therapy for stroke
risk prevention have been more widely implemented.3 Finally, our post-hoc sensitivity
analyses demonstrated that our results were robust to the following: (1) the exclusion of the
largest cohort11 in our study; (2) the exclusion of a study16 with imaging-based (timeindependent) definition of stroke which has the possibility of over-classifying TIAs as
strokes which would not be done in all other studies using the time-dependent, clinical
definitions; and 3) the exclusion of a study7 in which a subset of patients were followed for
first-time stroke whether or not they had an ipsilateral TIA that preceded the stroke.
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The mechanism underlying increased stroke risk in echolucent carotid artery plaque is not
entirely understood but is likely related to the echolucent appearance of high-risk elements
of atherosclerosis including lipid-rich necrotic core and intraplaque hemorrhage.4 The
relative proportion of these tissues is also uncertain though most histopathologic studies
suggest that lipid may be the largest plaque element by volume in echolucent plaque.5
However, the precise differentiation of tissues in echolucent plaque may be of limited
clinical significance, since most of these presumed tissue-types are features of more
advanced atherosclerotic lesions.10
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There are limitations of the ultrasonographic imaging methods used by the studies included
in this meta-analysis. First, we found a lack of consistency in the methods used to determine
plaque echolucency. More work is needed standardize the definitions of echolucency and
provide inter- and intra-observer variability measures of echolucency assessment. The role
of quantitative methods such as the use of gray-scale median values as well as the impact of
differences in ultrasound equipment on diagnostic accuracy and prediction of outcome also
requires additional study. In addition, future work is needed to understand how risk from
plaque echolucency could be incorporated in a multi-factorial risk assessment strategy in
which other presumptive stroke risk markers such as plaque ulceration are synthesized to
produce a composite risk score.18 It is important to remember that even assuming a 0.5 to
1% annual stroke risk in asymptomatic carotid stenosis ≥50%, that a 2.6 times higher RR of
stroke as seen with predominantly echolucent plaque will still require additional risk factors
to be taken into account to inform decisions with regard to a carotid procedure
supplementing modern medical therapy. The most meaningful improvements in risk
stratification in asymptomatic carotid stenosis may only occur when plaque echolucency is
combined with other risk markers such as clinical features, the degree of stenosis and other
imaging measures.18
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Several additional limitations of our study are important to consider. First, we noted that
most studies did not make clear what systematic efforts were used to assure complete
subject follow-up and thus it is unclear to what extent losses to follow-up may have
contributed to bias in our estimation of the relative risk associated with echolucent plaques.
Second, in the studies where blinding to test results was not performed, we believe that the
possibility of outcome ascertainment bias exists. Third, we studied only medically managed
asymptomatic patients and it is therefore unclear to what extent selection bias may have
influenced the risk profile of this group compared to asymptomatic patients undergoing
surgical revascularization. Fourth, we calculated unadjusted RRs. Since the covariate risk
factors, individual patient follow-up times, and medical therapies used varied so widely
across studies, the existing data is not amenable to the calculation of covariate-adjusted RRs
or annualized stroke risks. Fifth, most studies included patients with a wide range of carotid
stenosis including 2 studies in which carotid stenosis was not present in all subjects13,16 and
1 study11 in which a number of patients did not have any carotid plaque (stenosing or nonstenosing). However, specific breakdowns of subjects with and without stenosis were not
provided. Since some studies focused only on stenosis ≥50% or presented these data
separately, we were able to estimate a pooled RR for this group. However, the total study
data were not amenable to similar calculation of RR for only patients with low-grade carotid
stenosis (<50%) or non-stenosing carotid plaque. Finally, additional heterogeneity of the
studies in this meta-analysis arise from lack of clarity in reporting on asymptomatic carotid
disease including variability in the definition of stroke and symptomatic status, inconsistent
reporting of the nature of medical therapy received by subjects, and imprecision about the
classification of first-time versus recurrent ischemic events. Future studies in carotid disease
should rely on standardized definitions for these basic clinical features and outcome
measures so that studies can be understood, analyzed, and interpreted in a transparent and
clear fashion.
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In spite of these challenges and limitations, we believe that there is sufficient evidence to
conclude that ultrasound carotid plaque echolucency is a predictive risk factor for ipsilateral
stroke in patients across a wide range of carotid stenosis severity. Despite the limitations of
available research results, to our knowledge, our study is the best quality, most
comprehensive analysis of the predictive value of detecting plaque echolucency. Ultimately,
the validation of plaque echolucency and other risk markers to inform treatment decisions in
patients with asymptomatic carotid stenosis will require examination in high quality,
prospective longitudinal studies of patients receiving current optimal medical treatment.
Finally, although nearly 30% of subjects with ≥50% stenosis demonstrated plaque
echolucency, given the low absolute stroke risk in these patients, plaque echolucency alone
is not a powerful enough risk factor to select asymptomatic stenosis patients likely to benefit
from carotid endarterectomy or stenting.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
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Forest plot of the association between ultrasound-determined plaque echolucency and future
ipsilateral stroke. Meta-analysis calculated using a random-effects model. Squares represent
point estimates for the effect size expressed as a relative risk. The size of the squares is
proportional to the inverse of the variance of the estimate. Diamond represents the pooled
estimate and the horizontal lines represent the 95% confidence intervals.
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Figure 2.
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Forest plot of the association between ultrasound-determined plaque echolucency and future
ipsilateral stroke in the subgroup of patients with ≥50% stenosis. Meta-analysis calculated
using a random-effects model. Squares represent point estimates for the effect size expressed
as a relative risk. The size of the squares is proportional to the inverse of the variance of the
estimate. Diamond represents the pooled estimate and the horizontal lines represent the 95%
confidence intervals.
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